Examining the therapeutic landscape of beta-blockers in portal hypertension

Clin Mol Hepatol. 2024 Oct;30(4):1055-1059. doi: 10.3350/cmh.2024.0144. Epub 2024 Mar 6.

Anna Brujats¹, Càndid Villanueva^{1

2}

¹ Hospital Santa Creu and Sant Pau, Autonomous University of Barcelona, Hospital Sant Pau Biomedical Research Institute (IIB Sant Pau), Barcelona, Spain.
² Centre for Biomedical Research in Liver and Digestive Diseases Network (CIBERehd), Barcelona, Spain.

No abstract available

Keywords: Beta-adrenergic blockers; Clinically significant portal hypertension; Liver cirrhosis; Primary prevention.